Nizatidine
Top View
- Leading Article Gut: First Published As 10.1136/Gut.39.6.784 on 1 December 1996
- MTUS DRUG-LIST-V3-Addendum-One-Effective 10012018
- Prior Authorization PDL Implementation Schedule
- Modernized Reference Drug Program Histamine2 Receptor Blockers (H2 Blockers)
- In Vivo Pharmacodynamic Interaction Between Pipecuronium and Certain H2 Blockers
- The Association Between Ranitidine Use and Gastrointestinal Cancers
- Cimetidine Use and Risk of Prostate and Breast Cancer
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Appendix F9. University of Maryland Health Partners (UMHP) Prescription Drugs Subject to Nqtls, by Delivery System
- Potentially Harmful Drugs in the Elderly: Beers List and More
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- D Rug U Tilization R Eview B Oard
- Preferred Drug List (PDL)
- Lafutidine 10 Mg Versus Rabeprazole 20 Mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: a Randomized, Multicentric Trial
- Consultation: Cimetidine, Famotidine, Nizatidine and Ranitidine
- Preferred Drug List
- (CD-P-PH/PHO) Report Classification/Justifica
- YAMANOUCHI PHARM. CO. V. DANBURY PHAR. Yamamouchi’S Patent